Form 4 for LRCX Lam Research
Accepted 2023-08-02 00:00:00 ET · period of report 2023-08-01 · accession 0000707549-23-000095 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-08-02 | 2023-08-01 | LRCX | Vahedi Vahid | SVP | M - OptEx | $204.90 | +13.8K | 33.9K | +68% | +$2.82M |
| DM | 2023-08-02 | 2023-08-01 | LRCX | Vahedi Vahid | SVP | S - Sale+OE | $717.46 | -13.8K | 26.5K | -34% | -$9.87M |
| DM | 2023-08-02 | 2023-08-01 | LRCX | Vahedi Vahid | SVP | M - OptEx | $0.00 | -13.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-01 | M | A | 3,576 | $190.07 | 30,059 | D | — | — | (F1) The amount reported includes shares subject to unvested restricted stock units. |
| 2 | Common | Common Stock | 2023-08-01 | S | D | 2,748 | $717.23 | 26,483 | D | — | — | (F3) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $716.91 to $717.32, inclusive. (F1) The amount reported includes shares subject to unvested restricted stock units. |
| 3 | Common | Common Stock | 2023-08-01 | M | A | 2,748 | $300.33 | 29,231 | D | — | — | (F1) The amount reported includes shares subject to unvested restricted stock units. |
| 4 | Common | Common Stock | 2023-08-01 | S | D | 7,432 | $717.52 | 26,483 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $717.26 to $718.10, inclusive. (F1) The amount reported includes shares subject to unvested restricted stock units. |
| 5 | Common | Common Stock | 2023-08-01 | M | A | 7,432 | $176.75 | 33,915 | D | — | — | (F1) The amount reported includes shares subject to unvested restricted stock units. |
| 6 | Common | Common Stock | 2023-08-01 | S | D | 3,576 | $717.53 | 26,483 | D | — | — | (F1) The amount reported includes shares subject to unvested restricted stock units. |
| 7 | Derivative | Employee Stock Option (Right to Buy) | 2023-08-01 | M | D | 2,748 | $0.00 | 0 | D | $300.33 · — to 2027-03-02 | 2,748 Common Stock | (F6) The stock option becomes exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023. |
| 8 | Derivative | Employee Stock Option (Right to Buy) | 2023-08-01 | M | D | 3,576 | $0.00 | 0 | D | $190.07 · — to 2025-03-01 | 3,576 Common Stock | (F4) The stock option becomes exercisable in three equal installments on 03/01/2019, 03/01/2020, and 03/01/2021. |
| 9 | Derivative | Employee Stock Option (Right to Buy) | 2023-08-01 | M | D | 7,432 | $0.00 | 0 | D | $176.75 · — to 2026-03-01 | 7,432 Common Stock | (F5) The stock options will become exercisable in three equal installments on 03/01/2020, 03/01/2021, and 03/01/2022. |